QE side effect: Corporations are getting paid to borrow

We have all seen pharmaceutical commercials on TV where a listing of common side effects may include diarrhea, nausea and drowsiness. In today's financial markets, central banks are expanding their balance sheets by trillions of dollars annually and new side effects are on the way. This week saw a new milestone in the world of negative interest rates, when Henkel and Sanofi became the first public companies to sell new Euro bonds for more than the buyers will get back.

Yes, you read that correctly. Investors are paying for the privilege of loaning a corporation money. We first saw this with European and Japanese government bonds but this is a first for corporate bonds which carry significantly more credit risk. While this is a pretty horrible side effect for investors, it is essentially helicopter money for corporations who can take this "free" money to buyback shares, make acquisitions and/or invest it to grow their business. Henkel sold €500 million of 2-year debt with a yield of -0.05%; and Sanofi sold €1 billion of 3.5-year debt at a yield of -0.05%.

Thanks to aggressive bond purchases from the European Central Bank (ECB,) corporations are getting free money, and this trend is set to continue for the foreseeable future. The ECB launched its corporate bond buying program in June and has bought over €20 billion of corporate bonds as of Sep. 2. Yields on corporate debt have plunged in recent months as investors have pushed up prices in the scramble for returns. Roughly €706 billion of eurozone investment-grade corporate bonds traded at negative yields as of Sept. 5, or over 30% of the entire market, according to trading platform Tradeweb, up from roughly 5% of the market in early January.

Stock market side effects

With negative rates, it appears that the bond market is in bubble territory and one wonders how much further negative can rates go? In terms of the stock market, equities should remain favorable on a relative basis. If bonds have a negative yield, investors are forced to either sit on cash that earns nothing or they need to move to the equity market in search of high dividend paying stocks. We expect this bizarre situation in the bond market to continue pushing fund flows into equities.

If negative rates come to the US, what will your investment strategy be?

become_a_blog_subscriberget your risk number

Share This Story, Choose Your Platform!

About the Author: Chris Wang

Chris Wang


Please remember that past performance may not be indicative of future results.  Different types of investments involve varying degrees of risk, and there can be no assurance that the future performance of any specific investment, investment strategy, or product (including the investments and/or investment strategies recommended or undertaken by Runnymede Capital Management, Inc.-"Runnymede"), or any non-investment related content, made reference to directly or indirectly in this blog will be profitable, equal any corresponding indicated historical performance level(s), be suitable for your portfolio or individual situation, or prove successful.  Due to various factors, including changing market conditions and/or applicable laws, the content may no longer be reflective of current opinions or positions.  Moreover, you should not assume that any discussion or information contained in this blog serves as the receipt of, or as a substitute for, personalized investment advice from Runnymede.  Please remember that if you are a Runnymede client, it remains your responsibility to advise Runnymede, in writing, if there are any changes in your personal/financial situation or investment objectives for the purpose of reviewing/evaluating/revising our previous recommendations and/or services, or if you would like to impose, add, or to modify any reasonable restrictions to our investment advisory services. To the extent that a reader has any questions regarding the applicability of any specific issue discussed above to his/her individual situation, he/she is encouraged to consult with the professional advisor of his/her choosing. Runnymede is neither a law firm nor a certified public accounting firm and no portion of the blog content should be construed as legal or accounting advice. A copy of the Runnymede's current written disclosure Brochure discussing our advisory services and fees is available for review upon request. Please Note: Runnymede does not make any representations or warranties as to the accuracy, timeliness, suitability, completeness, or relevance of any information prepared by any unaffiliated third party, whether linked to Runnymede's web site or blog or incorporated herein, and takes no responsibility for any such content. All such information is provided solely for convenience purposes only and all users thereof should be guided accordingly.

Search Website

Annuity Review Database

Follow Our Podcast

Google Podcasts
Apple Podcasts

Recent Posts